Beta Drugs Ltd Competitors & Peer Comparison
Pharmaceuticals · Indian listed companies
Compare Beta Drugs Ltd with 125 companies shown from the same industry classification, including Hester Biosciences Ltd, Syncom Formulations (India) Ltd, Venus Remedies Ltd. These are industry peers; their products, customers and business models may differ.
Selected-company price and ratio data: . Peer reporting dates can differ. Stored figures, not live quotes.
Compare valuation, size and returns
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Beta Drugs Ltd | 1,940 Cr. | 1,750 | 2,808/990 | 42.6 | 241 | 0.00 % | 19.2 % | 18.8 % | 10.0 |
| Hester Biosciences Ltd | 1,878 Cr. | 2,196 | 2,684/1,239 | 35.4 | 423 | 0.50 % | 15.2 % | 15.9 % | 10.0 |
| Syncom Formulations (India) Ltd | 2,025 Cr. | 21.6 | 27.5/10.2 | 23.9 | 4.39 | 0.46 % | 24.8 % | 17.6 % | 1.00 |
| Venus Remedies Ltd | 2,084 Cr. | 1,572 | 2,044/432 | 17.9 | 497 | 0.64 % | 20.7 % | 15.6 % | 10.0 |
| Panacea Biotec Ltd | 2,182 Cr. | 357 | 648/292 | 136 | 0.00 % | 2.43 % | 2.42 % | 1.00 | |
| Indoco Remedies Ltd | 2,236 Cr. | 241 | 302/162 | 102 | 0.08 % | 0.96 % | 9.36 % | 2.00 | |
| Fermenta Biotech Ltd | 1,587 Cr. | 540 | 583/249 | 29.0 | 138 | 0.69 % | 20.6 % | 16.4 % | 5.00 |
| Dishman Carbogen Amcis Ltd | 2,372 Cr. | 151 | 306/128 | 131 | 426 | 0.00 % | 3.14 % | 1.58 % | 2.00 |
| TTK Healthcare Ltd | 1,460 Cr. | 1,033 | 1,250/735 | 19.1 | 789 | 0.97 % | 8.04 % | 6.30 % | 10.0 |
| Amrutanjan Health Care Ltd | 1,456 Cr. | 503 | 760/476 | 23.4 | 128 | 0.97 % | 24.8 % | 18.4 % | 1.00 |
| Jagsonpal Pharmaceuticals Ltd | 1,446 Cr. | 219 | 265/155 | 30.8 | 41.2 | 1.83 % | 22.7 % | 17.3 % | 2.00 |
| Fredun Pharmaceuticals Ltd | 2,529 Cr. | 1,532 | 1,666/454 | 56.9 | 170 | 0.02 % | 21.5 % | 15.8 % | 10.0 |
| Kopran Ltd | 1,328 Cr. | 274 | 296/107 | 53.1 | 110 | 1.10 % | 6.65 % | 4.91 % | 10.0 |
| Hikal Ltd | 2,671 Cr. | 216 | 261/146 | 63.0 | 97.2 | 0.28 % | 3.50 % | 2.21 % | 2.00 |
| Lincoln Pharmaceuticals Ltd | 1,110 Cr. | 555 | 770/440 | 11.5 | 378 | 0.32 % | 16.0 % | 12.0 % | 10.0 |
| Bafna Pharmaceuticals Ltd | 1,052 Cr. | 452 | 460/94.8 | 135 | 40.6 | 0.00 % | 11.9 % | 12.3 % | 10.0 |
| Themis Medicare Ltd | 979 Cr. | 106 | 141/65.0 | 43.3 | 0.47 % | 2.74 % | 0.41 % | 1.00 | |
| Advanced Enzyme Technologies Ltd | 3,016 Cr. | 269 | 420/252 | 19.1 | 146 | 1.98 % | 14.0 % | 10.2 % | 2.00 |
| Anuh Pharma Ltd | 837 Cr. | 83.7 | 99.5/66.7 | 19.0 | 35.1 | 1.79 % | 14.9 % | 10.7 % | 5.00 |
| Kilitch Drugs (India) Ltd | 825 Cr. | 236 | 268/117 | 27.4 | 80.0 | 0.00 % | 13.4 % | 10.6 % | 10.0 |
| Ind-Swift Laboratories Ltd | 3,114 Cr. | 358 | 425/87.0 | 47.8 | 159 | 0.00 % | 4.86 % | 4.02 % | 10.0 |
| Solara Active Pharma Sciences Ltd | 3,150 Cr. | 649 | 774/422 | 738 | 346 | 0.00 % | 4.86 % | 0.13 % | 10.0 |
| Wanbury Ltd | 650 Cr. | 186 | 360/162 | 15.1 | 18.1 | 0.00 % | 36.6 % | 76.5 % | 10.0 |
| Albert David Ltd | 462 Cr. | 804 | 932/580 | 20.5 | 686 | 0.62 % | 0.82 % | 0.44 % | 10.0 |
| Kwality Pharmaceuticals Ltd | 3,443 Cr. | 3,316 | 3,949/829 | 42.2 | 321 | 0.00 % | 23.9 % | 22.5 % | 10.0 |
| SMS Lifesciences India Ltd | 357 Cr. | 1,197 | 1,680/956 | 20.6 | 650 | 0.13 % | 11.8 % | 10.8 % | 10.0 |
| Aarey Drugs & Pharmaceuticals Ltd | 350 Cr. | 109 | 110/50.3 | 84.0 | 53.0 | 0.00 % | 5.58 % | 2.75 % | 10.0 |
| Lyka Labs Ltd | 301 Cr. | 83.6 | 105/44.1 | 25.9 | 0.00 % | 5.98 % | 10.2 % | 10.0 | |
| BDH Industries Ltd | 242 Cr. | 421 | 610/340 | 20.7 | 134 | 1.19 % | 20.5 % | 14.8 % | 10.0 |
| Everest Organics Ltd | 241 Cr. | 242 | 536/197 | 45.9 | 77.7 | 0.00 % | 12.0 % | 7.63 % | 10.0 |
| Gennex Laboratories Ltd | 237 Cr. | 9.77 | 17.2/7.05 | 12.6 | 9.16 | 0.00 % | 11.8 % | 10.5 % | 1.00 |
| Unichem Laboratories Ltd | 3,669 Cr. | 521 | 687/278 | 30.0 | 386 | 0.00 % | 4.13 % | 3.17 % | 2.00 |
| Brooks Laboratories Ltd | 207 Cr. | 70.4 | 131/36.3 | 15.7 | 41.6 | 0.00 % | 21.2 % | 22.0 % | 10.0 |
| Aarti Drugs Limited | 3,675 Cr. | 403 | 534/319 | 21.2 | 154 | 0.50 % | 11.7 % | 12.7 % | 10.0 |
| Ambalal Sarabhai Enterprises Ltd | 203 Cr. | 26.5 | 42.0/23.1 | 11.4 | 19.2 | 0.00 % | 9.12 % | 6.25 % | 10.0 |
| Nectar Lifescience Ltd | 196 Cr. | 10.0 | 22.5/9.20 | 30.0 | 0.00 % | 0.05 % | 31.3 % | 1.00 | |
| Coral Laboratories Ltd | 193 Cr. | 540 | 679/360 | 10.2 | 585 | 0.37 % | 11.0 % | 7.79 % | 10.0 |
| Bal Pharma Ltd | 156 Cr. | 97.7 | 125/59.7 | 21.6 | 51.6 | 1.23 % | 9.75 % | 7.79 % | 10.0 |
| Godavari Drugs Ltd | 141 Cr. | 129 | 135/69.7 | 36.2 | 74.8 | 0.00 % | 6.55 % | 6.14 % | 10.0 |
| Gujarat Inject (Kerala) Ltd | 139 Cr. | 9.49 | 14.3/1.96 | 46.3 | 0.81 | 0.00 % | 22.9 % | 16.6 % | 1.00 |
| Auro Laboratories Ltd | 138 Cr. | 221 | 317/159 | 28.8 | 74.4 | 0.00 % | 9.52 % | 8.49 % | 10.0 |
| Par Drugs & Chemicals Ltd | 137 Cr. | 111 | 180/78.0 | 9.44 | 91.0 | 0.00 % | 14.6 % | 9.95 % | 10.0 |
| Lactose (India) Ltd | 135 Cr. | 107 | 136/76.0 | 19.4 | 51.5 | 0.00 % | 11.3 % | 9.81 % | 10.0 |
| Achyut Healthcare Ltd | 132 Cr. | 5.47 | 10.0/4.70 | 413 | 1.45 | 0.00 % | 1.18 % | 0.96 % | 1.00 |
| Krebs Biochemicals & Industries Ltd | 130 Cr. | 60.8 | 76.8/38.3 | 75.5 | 0.00 % | 15.4 % | % | 10.0 | |
| Alpa Laboratories Ltd | 122 Cr. | 58.3 | 99.8/46.0 | 28.0 | 93.4 | 0.00 % | 8.91 % | 7.90 % | 10.0 |
| Pharmaids Pharmaceuticals Ltd | 107 Cr. | 30.4 | 53.9/25.6 | 13.5 | 0.00 % | 18.5 % | 26.5 % | 10.0 | |
| Vaishali Pharma Ltd | 102 Cr. | 7.79 | 11.2/4.75 | 24.0 | 5.29 | 0.00 % | 8.93 % | 6.02 % | 2.00 |
| Concord Drugs Ltd | 93.5 Cr. | 71.0 | 92.5/61.0 | 45.8 | 36.8 | 0.00 % | 5.19 % | 2.52 % | 10.0 |
| Denis Chem Lab Ltd | 90.7 Cr. | 65.4 | 94.6/56.1 | 11.4 | 66.0 | 3.83 % | 14.0 % | 9.52 % | 10.0 |
| Ind-Swift Ltd | 85.4 Cr. | 15.8 | / | 10.9 | 74.2 | 0.00 % | 11.9 % | % | 2.00 |
| Fervent Synergies Ltd | 74.4 Cr. | 14.9 | 26.0/13.0 | 20.4 | 11.4 | 0.00 % | 7.21 % | 7.22 % | 10.0 |
| Cian Healthcare Ltd | 63.6 Cr. | 25.4 | 25.4/4.72 | 3.42 | 0.00 % | 15.1 % | 49.2 % | 10.0 | |
| Vivimed Labs Ltd | 56.5 Cr. | 6.71 | 29.4/4.75 | 25.4 | 0.00 % | 65.2 % | % | 2.00 | |
| Mangalam Drugs and Organics Ltd | 50.5 Cr. | 31.6 | 73.0/22.7 | 65.3 | 0.00 % | 13.8 % | 34.8 % | 10.0 | |
| Biofil Chemicals & Pharmaceuticals Ltd | 47.9 Cr. | 29.9 | 46.8/25.6 | 99.8 | 13.2 | 0.00 % | 2.97 % | 2.83 % | 10.0 |
| ANG Lifesciences India Ltd | 47.2 Cr. | 36.2 | 49.7/17.6 | 47.6 | 0.00 % | 1.14 % | 7.38 % | 10.0 | |
| Bharat Immunological & Biological Corporation Ltd | 41.3 Cr. | 9.56 | 22.6/7.11 | 18.2 | 0.00 % | 9.27 % | 17.7 % | 10.0 | |
| Murae Organisor Ltd | 38.8 Cr. | 0.19 | 0.44/0.19 | 2.56 | 1.02 | 0.00 % | 4.20 % | 5.69 % | 1.00 |
| Bacil Pharma Ltd | 31.5 Cr. | 22.0 | 61.8/10.6 | 50.0 | 17.6 | 0.00 % | 3.93 % | 6.21 % | 10.0 |
| Chandra Bhagat Pharma Ltd | 28.8 Cr. | 38.2 | 53.0/29.7 | 9.45 | 43.9 | 0.00 % | 12.1 % | 9.67 % | 10.0 |
| Gujarat Terce Laboratories Ltd | 27.6 Cr. | 35.4 | 59.8/29.0 | 12.4 | 12.5 | 0.00 % | 39.2 % | 30.2 % | 10.0 |
| Colinz Laboratories Ltd | 18.5 Cr. | 73.5 | 87.9/36.1 | 37.0 | 39.9 | 0.00 % | 7.20 % | 5.23 % | 10.0 |
| Checkpoint Trends Ltd | 17.3 Cr. | 31.6 | 144/28.4 | 14.1 | 42.5 | 0.00 % | 15.0 % | 12.7 % | 10.0 |
| Ortin Laboratories Ltd | 16.4 Cr. | 20.1 | 26.4/16.2 | 3.47 | 0.00 % | 60.2 % | 118 % | 10.0 | |
| Desh Rakshak Aushdhalaya Ltd | 15.3 Cr. | 26.9 | 59.6/22.4 | 27.9 | 23.3 | 0.00 % | 7.50 % | 5.59 % | 10.0 |
| Chemo Pharma Laboratories Ltd | 13.6 Cr. | 91.0 | 153/70.0 | 8.60 | 0.00 % | 0.28 % | 0.28 % | 10.0 | |
| Beryl Drugs Ltd | 11.8 Cr. | 23.4 | 27.6/15.9 | 19.1 | 19.5 | 0.00 % | 7.25 % | 4.34 % | 10.0 |
| Dipna Pharmachem Ltd | 10.2 Cr. | 3.89 | 25.0/3.89 | 3.89 | 23.7 | 0.00 % | 7.64 % | 5.22 % | 10.0 |
| Adline Chem Lab Ltd | 9.24 Cr. | 15.8 | 16.2/7.60 | 3.03 | 0.00 % | 1,267 % | % | 10.0 | |
| Brawn Biotech Ltd | 7.62 Cr. | 25.4 | 25.7/17.7 | 8.96 | 14.5 | 0.00 % | 0.00 % | 24.4 % | 10.0 |
| Ganga Pharmaceuticals Ltd | 7.39 Cr. | 12.5 | 14.0/9.35 | 73.9 | 14.1 | 0.00 % | 2.90 % | 1.30 % | 10.0 |
| Decipher Labs Ltd | 5.75 Cr. | 5.69 | 11.0/5.00 | 20.5 | 0.00 % | 16.7 % | 14.2 % | 10.0 | |
| Amerise Biosciences Ltd | 5.55 Cr. | 0.84 | 1.03/0.50 | 0.82 | 0.00 % | 0.37 % | 0.37 % | 1.00 | |
| Fabino Enterprises Ltd | 4.27 Cr. | 20.3 | 27.0/13.0 | 18.7 | 0.00 % | 6.22 % | 8.76 % | 10.0 | |
| Evoq Remedies Ltd | 4.08 Cr. | 1.64 | 6.11/1.35 | 17.8 | 0.00 % | 0.56 % | 0.54 % | 10.0 | |
| MPS Pharmaa Ltd | 3.98 Cr. | 2.08 | 2.08/1.57 | 0.04 | 0.00 % | 13.1 % | 177 % | 10.0 | |
| SMS Pharmaceuticals Ltd | 3,977 Cr. | 425 | 494/270 | 43.9 | 85.9 | 0.09 % | 12.9 % | 11.9 % | 1.00 |
| Gufic BioSciences Ltd | 4,104 Cr. | 408 | 468/268 | 55.8 | 66.2 | 0.02 % | 12.2 % | 9.98 % | 1.00 |
| RPG Life Sciences Ltd | 4,608 Cr. | 2,778 | 3,130/1,731 | 39.5 | 366 | 0.86 % | 25.7 % | 19.3 % | 8.00 |
| Zota Health Care Ltd | 4,739 Cr. | 1,368 | 1,740/1,022 | 200 | 0.07 % | 8.47 % | 15.0 % | 10.0 | |
| Gujarat Themis Biosyn Ltd | 4,812 Cr. | 370 | 479/225 | 98.9 | 26.4 | 0.18 % | 18.1 % | 17.4 % | 1.00 |
| Orchid Pharma Ltd | 5,545 Cr. | 928 | 1,144/471 | 307 | 300 | 0.00 % | 1.86 % | 1.49 % | 10.0 |
| FDC Ltd | 5,710 Cr. | 351 | 474/313 | 18.5 | 153 | 1.42 % | 15.4 % | 11.2 % | 1.00 |
| IOL Chemicals & Pharmaceuticals Ltd | 5,727 Cr. | 195 | 224/67.1 | 32.4 | 61.3 | 0.51 % | 11.3 % | 8.42 % | 2.00 |
| Sanofi India Ltd | 6,809 Cr. | 2,957 | 4,898/2,907 | 19.9 | 359 | 2.54 % | 57.5 % | 43.0 % | 10.0 |
| Morepen Laboratories Ltd | 6,908 Cr. | 126 | 151/33.0 | 58.8 | 22.8 | 0.16 % | 8.05 % | 5.33 % | 2.00 |
| Bliss GVS Pharma Ltd | 6,953 Cr. | 654 | 745/118 | 50.5 | 113 | 0.23 % | 16.9 % | 11.8 % | 1.00 |
| Entero Healthcare Solutions Ltd | 7,349 Cr. | 1,689 | 1,920/944 | 57.0 | 388 | 0.00 % | 10.5 % | 6.94 % | 10.0 |
| Aarti Pharmalabs Ltd | 7,844 Cr. | 864 | 1,002/584 | 36.4 | 234 | 0.41 % | 10.7 % | 8.59 % | 5.00 |
| Procter & Gamble Health Ltd | 8,518 Cr. | 5,149 | 6,975/4,700 | 25.6 | 316 | 3.01 % | 83.9 % | 61.9 % | 10.0 |
| Suven Life Sciences Ltd | 8,538 Cr. | 300 | 403/124 | 22.4 | 0.00 % | 79.5 % | 81.5 % | 1.00 | |
| Sequent Scientific Ltd | 8,768 Cr. | 201 | 260/111 | 203 | 32.2 | 0.00 % | 8.47 % | 3.21 % | 2.00 |
| Blue Jet Healthcare Ltd | 9,824 Cr. | 519 | 693/325 | 41.8 | 78.4 | 0.23 % | 26.1 % | 19.4 % | 2.00 |
| Concord Biotech Ltd | 13,948 Cr. | 1,331 | 1,627/987 | 49.0 | 193 | 0.57 % | 17.4 % | 12.6 % | 1.00 |
| Marksans Pharma Ltd | 13,951 Cr. | 308 | 351/155 | 27.0 | 66.7 | 0.29 % | 18.8 % | 15.2 % | 1.00 |
| Astrazeneca Pharma India Ltd | 14,860 Cr. | 5,937 | 9,850/5,640 | 85.7 | 349 | 0.61 % | 29.3 % | 23.3 % | 2.00 |
| Jubilant Pharmova Ltd | 14,945 Cr. | 938 | 1,185/784 | 38.5 | 445 | 0.53 % | 8.99 % | 6.53 % | 1.00 |
| Natco Pharma Ltd | 15,391 Cr. | 785 | 1,217/779 | 13.4 | 470 | 0.64 % | 17.4 % | 17.1 % | 2.00 |
| Alembic Pharmaceuticals Ltd | 15,588 Cr. | 792 | 998/635 | 20.9 | 289 | 1.51 % | 12.6 % | 13.4 % | 2.00 |
| ERIS Lifesciences Ltd | 15,947 Cr. | 1,149 | 1,740/1,138 | 24.3 | 282 | 0.63 % | 14.1 % | 18.7 % | 1.00 |
| Pfizer Ltd | 17,434 Cr. | 3,811 | 5,448/3,731 | 22.7 | 919 | 1.97 % | 24.1 % | 18.0 % | 10.0 |
| Caplin Point Laboratories Ltd | 17,506 Cr. | 2,302 | 2,991/1,500 | 26.3 | 443 | 0.35 % | 24.2 % | 20.9 % | 2.00 |
| Cohance Lifesciences Ltd | 17,580 Cr. | 460 | 918/267 | 163 | 102 | 0.00 % | 5.81 % | 4.89 % | 1.00 |
| Shilpa Medicare Ltd | 18,037 Cr. | 922 | 1,096/260 | 63.4 | 132 | 0.07 % | 10.9 % | 8.99 % | 1.00 |
| Granules India Ltd | 22,180 Cr. | 812 | 924/520 | 34.1 | 205 | 0.22 % | 15.5 % | 13.8 % | 1.00 |
| Neuland Laboratories Ltd | 25,602 Cr. | 19,955 | 24,235/11,500 | 51.4 | 1,461 | 0.17 % | 26.5 % | 21.2 % | 10.0 |
| Acutaas Chemicals Ltd | 25,642 Cr. | 3,132 | 3,740/1,528 | 66.4 | 202 | 0.08 % | 31.6 % | 24.0 % | 5.00 |
| Wockhardt Ltd | 31,671 Cr. | 1,949 | 2,422/1,087 | 79.4 | 304 | 0.00 % | 7.55 % | 6.11 % | 5.00 |
| J B Chemicals & Pharmaceuticals Ltd | 38,677 Cr. | 2,409 | 2,526/1,655 | 53.8 | 259 | 0.91 % | 25.4 % | 18.9 % | 1.00 |
| Ajanta Pharma Ltd | 41,609 Cr. | 3,343 | 3,797/2,382 | 36.7 | 362 | 0.96 % | 34.5 % | 27.1 % | 2.00 |
| Glaxosmithkline Pharmaceuticals Ltd | 42,762 Cr. | 2,525 | 3,121/2,088 | 40.6 | 134 | 2.26 % | 61.4 % | 45.6 % | 10.0 |
| Ipca Laboratories Ltd | 48,484 Cr. | 1,913 | 2,039/1,252 | 35.3 | 318 | 0.31 % | 17.0 % | 15.7 % | 1.00 |
| Gland Pharma Ltd | 50,585 Cr. | 3,066 | 3,171/1,574 | 35.8 | 656 | 0.65 % | 17.4 % | 12.8 % | 1.00 |
| Abbott India Ltd | 55,292 Cr. | 26,070 | 30,655/25,135 | 34.2 | 2,247 | 2.01 % | 44.8 % | 34.4 % | 10.0 |
| Biocon Ltd | 57,259 Cr. | 352 | 447/338 | 78.7 | 210 | 0.14 % | 3.61 % | 1.40 % | 5.00 |
| Glenmark Life Sciences Ltd | 62,243 Cr. | 2,210 | 2,538/1,793 | 20.0 | 372 | 0.23 % | 39.8 % | 23.6 % | 1.00 |
| Alkem Laboratories Ltd | 62,514 Cr. | 5,214 | 5,934/5,051 | 27.5 | 1,156 | 1.02 % | 21.2 % | 18.9 % | 2.00 |
| Glenmark Pharmaceuticals Ltd | 63,557 Cr. | 2,250 | 2,538/1,793 | 20.4 | 372 | 0.22 % | 39.8 % | 23.6 % | 1.00 |
| Lupin Ltd | 90,510 Cr. | 1,981 | 2,530/1,900 | 15.2 | 491 | 0.91 % | 29.9 % | 28.7 % | 2.00 |
| Aurobindo Pharma Ltd | 96,633 Cr. | 1,678 | 1,740/1,080 | 25.6 | 652 | 0.24 % | 12.9 % | 10.1 % | 1.00 |
| Mankind Pharma Ltd | 97,170 Cr. | 2,348 | 2,642/1,910 | 43.0 | 397 | 0.04 % | 13.7 % | 13.8 % | 1.00 |
| Dr Reddys Laboratories Ltd | 1,01,890 Cr. | 1,219 | 1,415/1,080 | 31.6 | 454 | 0.66 % | 13.0 % | 11.2 % | 1.00 |
| Cipla Ltd | 1,07,428 Cr. | 1,328 | 1,673/1,166 | 30.0 | 426 | 0.98 % | 15.5 % | 11.6 % | 2.00 |
| Laurus Labs Ltd | 1,09,110 Cr. | 2,018 | 2,071/870 | 125 | 97.3 | 0.10 % | 16.0 % | 15.2 % | 2.00 |
| Torrent Pharmaceuticals Ltd | 1,73,833 Cr. | 4,584 | 5,250/3,506 | 77.9 | 248 | 0.83 % | 15.2 % | 27.4 % | 5.00 |
| Industry Average | 17,096.69 Cr | 1,204.61 | 53.02 | 211.25 | 0.40% | 26.15% | 16.59% | 6.06 |
How to use this peer comparison
Start with similar company sizes, then compare P/E with ROCE and ROE. A lower P/E alone does not establish better value. Negative earnings, unusual items, debt and different reporting dates can make ratios unsuitable for direct comparison.
The company list is ordered by market-cap proximity to Beta Drugs Ltd, with P/E as a secondary comparison. The industry-average row uses available stored values across the industry, which can include companies beyond the rows shown. Missing values are not zero.
Open each company report for financial statements and its cited sources. Industry classifications indicate a research peer group, not a verified list of direct commercial competitors.
Read the full Beta Drugs Ltd analysis · Explore all Pharmaceuticals stocks